N-[4-[(1R)-1-氨基乙基]苯基]乙酰胺 | 177948-74-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-[4-[(1R)-1-氨基乙基]苯基]乙酰胺
• 中文别名: (R)-N-[4-(1-氨乙基)苯基]-乙酰胺
• 英文名称: (R)-N-[4-(1-aminoethyl)phenyl]acetamide
• 英文别名: (R)-1-(4-acetamidophenyl) ethylamine；(R)-1-(4-acetamidophenyl)-ethylamine；(R)-N-(4-(1-Aminoethyl)phenyl)acetamide；N-[4-[(1R)-1-aminoethyl]phenyl]acetamide
• CAS: 177948-74-2
• 化学式: C₁₀H₁₄N₂O
• 分子量: 178.234
• InChiKey: ZORYGMLNMVLIDS-SSDOTTSWSA-N

物化性质

• 沸点：
  367.9±25.0 °C(Predicted)
• 密度：
  1.115±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  55.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-叔-丁基苄基异硫氰酸酯 、 N-[4-[(1R)-1-氨基乙基]苯基]乙酰胺 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 N-[4-[(1R)-1-[(4-tert-butylphenyl)methylcarbamothioylamino]ethyl]phenyl]acetamide
  参考文献：
  名称：

  Chain-branched 1,3-dibenzylthioureas as vanilloid receptor 1 antagonists

  摘要：

  A series of chain-branched 1,3-dibenzylthiourea derivatives were synthesized, and tested their antagonist activity against vanilloid receptor 1. Chain-branching led to a significant change in the mode of action and the potency. (R)-Methyl or ethyl-branched 1,3-dibenzylthiourea derivatives showed the most potent antagonist activity up to the IC50 value of 0.05 muM which is 10-fold more potent than capsazepine. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.01.066
• 作为产物：
  描述：

  (R)-α-methyl-4-nitrobenzylamine hydrochloride 在 palladium on activated charcoal 吡啶 、 氢气 、 碳酸氢钠 、 三氟乙酸 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 生成 N-[4-[(1R)-1-氨基乙基]苯基]乙酰胺
  参考文献：
  名称：

  Chain-branched 1,3-dibenzylthioureas as vanilloid receptor 1 antagonists

  摘要：

  A series of chain-branched 1,3-dibenzylthiourea derivatives were synthesized, and tested their antagonist activity against vanilloid receptor 1. Chain-branching led to a significant change in the mode of action and the potency. (R)-Methyl or ethyl-branched 1,3-dibenzylthiourea derivatives showed the most potent antagonist activity up to the IC50 value of 0.05 muM which is 10-fold more potent than capsazepine. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.01.066

文献信息

• Azetidine, pyrrolidine and piperidine derivatives
  申请人：Merck Sharp & Dohme, Ltd.

  公开号：US05854268A1

  公开（公告）日：1998-12-29

  A class of substituted azetidine, pyrrolidine and piperidine derivatives are selective agonists of 5-HT.sub.1 -like receptors, being potent agonists of the human 5-HT.sub.1D.alpha. receptor subtype whilst possessing at least a 10-fold selective affinity for the 5-HT.sub.1D.alpha. receptor subtype relative to the 5-HT.sub.1D.beta. subtype; they are therefore useful in the treatment and/or prevention of clinical conditions, in particular migraine and associated disorders, for which a subtype-selective agonist of 5-HT.sub.1D receptors is indicated, whilst eliciting fewer side-effects, notably adverse cardiovascular events, than those associated with non-subtype-selective 5-HT.sub.1D receptor agonists.

  一类取代的氮杂环丙烷、吡咯烷和哌啶衍生物是5-HT.sub.1-类受体的选择性激动剂，是人类5-HT.sub.1D.alpha.受体亚型的有效激动剂，同时相对于5-HT.sub.1D.beta.亚型具有至少10倍的选择性亲和力；因此，在治疗和/或预防临床疾病方面具有用处，特别是偏头痛及相关疾病，需要5-HT.sub.1D受体的亚型选择性激动剂，同时引起的副作用较少，尤其是不良心血管事件，比与非亚型选择性5-HT.sub.1D受体激动剂相关的副作用。
• 3-[3-(Piperidin-1-yl)propyl]indoles as Highly Selective h5-HT_1D Receptor Agonists
  作者：Michael G. N. Russell、Victor G. Matassa、Roy R. Pengilley、Monique B. van Niel、Bindi Sohal、Alan P. Watt、Laure Hitzel、Margaret S. Beer、Josephine A. Stanton、Howard B. Broughton、José L. Castro

  DOI：10.1021/jm9910021

  日期：1999.12.2

  5-HT(1D/1B) receptor agonists are now entering the marketplace as treatments for migraine. This paper describes the development of selective h5-HT(1D) receptor agonists as potential antimigraine agents which may produce fewer side effects. A series of 3-[3-(piperidin-1-yl)propyl]indoles has been synthesized which has led to the identification of 80 (L-772,405), a high-affinity h5-HT(1D) receptor full agonist

  几种5-HT（1D / 1B）受体激动剂目前正作为偏头痛的治疗方法进入市场。本文介绍了选择性的h5-HT（1D）受体激动剂作为潜在的偏头痛药物的发展，它可能产生较少的副作用。合成了一系列3- [3-（哌啶-1-基）丙基]吲哚，该化合物导致鉴定出80（L-772,405），这是一种具有170的高亲和力h5-HT（1D）受体全激动剂对h5-HT（1D）受体的选择性是h5-HT（1B）受体的两倍。L-772,405在一系列其他5-羟色胺和非5-羟色胺受体上也表现出非常好的选择性，并且在大鼠皮下给药后具有出色的生物利用度。因此，它构成了描述偏头痛中h5-HT（1D）受体作用的有价值的工具。
• US5854268A
  申请人：——

  公开号：US5854268A

  公开（公告）日：1998-12-29
• Chain-branched 1,3-dibenzylthioureas as vanilloid receptor 1 antagonists
  作者：Chong Hyun Ryu、Mi Jung Jang、Jeong Wha Jung、Ju-Hyun Park、Hye Young Choi、Young-ger Suh、Uhtaek Oh、Hyeung-geun Park、Jeewoo Lee、Hyun-Joo Koh、Joo-Hyun Mo、Yung Hyup Joo、Young-Ho Park、Hee-Doo Kim

  DOI：10.1016/j.bmcl.2004.01.066

  日期：2004.4

  A series of chain-branched 1,3-dibenzylthiourea derivatives were synthesized, and tested their antagonist activity against vanilloid receptor 1. Chain-branching led to a significant change in the mode of action and the potency. (R)-Methyl or ethyl-branched 1,3-dibenzylthiourea derivatives showed the most potent antagonist activity up to the IC50 value of 0.05 muM which is 10-fold more potent than capsazepine. (C) 2004 Elsevier Ltd. All rights reserved.